Patient Summary
| Patient ID | P-2025-00002 |
| Age / Sex | 47 / Female |
| Ward | Maternity |
| Sample | Urine |
| Collected | 19 Feb 2025 04:35 |
Diagnostic Prediction
Likely Organism
🦠
Confidence: High
Antibiotic Recommendation
Recommended
Ceftazidime-avibactam
Why this drug?
- ✓ High predicted efficacy
- ✓ Active against detected resistance genes
- ✓ Good penetration (blood)
Confidence 94%
Resistance Prediction
| Antibiotic | Prediction | Probability |
|---|
| Meropenem |
Resistant |
95% |
| Ciprofloxacin |
Resistant |
88% |
| Gentamicin |
Sensitive |
76% |
| Amikacin |
Sensitive |
72% |
| Colistin |
Sensitive |
90% |
Explainable AI (Why resistance predicted?)
- ✓ Previous carbapenem exposure
- ✓ ICU admission
- ✓ Hospital stay > 14 days
- ✓ blaNDM gene detected
- ✓ IncX3 plasmid detected
- ✓ High bacterial load
Patient Risk Score
Risk Level LOW RISK
Mortality Risk (30 days) 6%
REI Score Trend (Last 14 days)
Resistance Probability Profile
📊 REI Score 19 Low
🔔 Alerts 2 Active
⌛ Sample Turnaround 5h 12m (In Progress)